Searched for
MESALAMINE TABLETS
Market Movers: IRCTC, YES Bank, Granules India rally; 66 stocks flash ‘buy’ signalSensex dropped 106 points to close at 41,460, while Nifty dipped 0.22% to settle at 12,175.- Cadila Healthcare Q2 profit up 32% at Rs 503 crore
- Zydus Cadila gets USFDA nod for its ulcerative colitis drugThe company has received final approval from the USFDA for Mesalamine delayed-release tablets in the strength of 800 mg, Zydus Cadila said ...
- Zydus Cadila launches anti-ulcer drug in USThe Gujarat-based group has more than 130 USFDA approvals and has filed over 300 abbreviated new drug applications (ANDAs) since it commenc...
- Cadila receives audit closure reportThe Moraiya manufacturing plant had completed the USFDA audit from February 6th to 15th 2017 with Zero 483 observations, the company said.
- RCom, Infy, Videocon and SBI most buzzing stocks of the weekFrom May 19’s closing of Rs 100.45, Videocon has lost 71.5% to close last week at Rs 28.55.
- Buy Cadila Healthcare Ltd. target Rs 600 : Edelweiss Financial ServicesBuy Cadila Healthcare Ltd. at a price target of Rs 600. Edelweiss says Cadila's US business growth will be best-in-class at 48 per cent wit...
- Cadila Healthcare scales record high on USFDA approvalThe USFDA has given its final approval to market mesalamine delayed-release tablets USP 1.2 g in the US market.
- Zydus Cadila gets USFDA nod for mesalamine tabletsZydus Cadila was the first to file an Abbreviated New Drug Application (ANDA) for the generic version of Lialda (mesalamine), the company s...
- Warner Chilcott & Cadila Healthcare settles patent litigationIndia's fifth largest drug maker by revenue, Zydus Cadila Group has settled a patent litigation with US-based Warner Chilcott Company LLC.
- Cadila Healthcare inks pact with Warner Chilcott to settle patent disputeCadila Healthcare along with Zydus Pharmaceuticals have entered into an agreement with Warner Chilcott Company to settle all outstanding pa...
- Zydus Cadila faces patent suit in US over drug AsocolUS based Warner Chilcott Plc has moved court against Zydus Cadila's plan to produce a bowel inflammation drug Asocol.
- Zydus arm, Irish co in patent disputeThe Rs 3,700-crore Zydus Group’s US subsidiary Zydus Pharmaceuticals USA has challenged the Irish company Shire Pharmaceuticals over its pa...
- P&G to sell global pharma biz for $3.1 bnAmerican consumer products major Procter & Gamble Company will be selling its global pharmaceuticals business to Ireland-based pharma entit...
Load More
